First-line eradication treatment of Helicobacter pylori infection: clinical trial without placebo, randomized, multi-center and three parallel treatment groups comparing classic triple therapy versus modified sequential therapy and other concomitant therapy.

ABSTRACT: Primary objectives: Evaluation of the efficacy of eradication treatment of Helicobacter pylori. Proportion of eradication of H. pylori assessed at least 4 weeks after treatment is completed by the breath test, or alternatively, by urease test or histology when revision endoscopy is necessary Primary endpoints: Efficacy in the eradication of antibiotic treatment in patients infected with Helicobacter pylori by breath test or histology, urease test or endoscopy if you need review

DISEASE(S): Helicobacter Pylori Infection,Clinical Situations Where It Is Recommended The Eradication Of Helicobacter Pylori: - Gastric Or Duodenal Ulcer (active Or Not) And Duodenal Erosions - Gastric Malt Lymphoma - First-degree Relatives Of Patients With Gastric Cancer - Intestinal Metaplasia With High-risk Histologic Criteria - Functional Dyspepsia Whose Clinical Symptom Persists Despite Treatment With Proton Pump Inhibitors (ppis) And / Or Prokinetic,Clinical Situations Where It Is Recommended The Eradication Of Helicobacter Pylori: - Gastric Or Duodenal Ulcer (active Or Not) And Duodenal Erosions - Gastric Malt Lymphoma - First-degree Relat...,Situaciones Clínicas Donde Esté Recomendada La Erradicación De Helicobacter Pylori:- Úlcera Gástrica O Duodenal (activa O No) Y Erosiones Duodenales- Linfoma Malt Gástrico- Familiares De Primer Grado De Pacientes Con Cáncer Gástrico- Metaplasia Intestinal Con Criterio Histológico De Alto Riesgo- Dispepsia Funcional Cuya Clínica Persiste Pese Al Tratamiento Sintomático Con Inhibidores De Bomba De Protones (ibp) Y/o Procinéticos

PROVIDER: 2530445 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR